385 related articles for article (PubMed ID: 33932330)
21. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
[TBL] [Abstract][Full Text] [Related]
22. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa.
Arrivé E; Dicko F; Amghar H; Aka AE; Dior H; Bouah B; Traoré M; Ogbo P; Dago-Akribi HA; Eboua TK; Kouakou K; Sy HS; Alioum A; Dabis F; Ekouévi DK; Leroy V;
PLoS One; 2012; 7(3):e33690. PubMed ID: 22457782
[TBL] [Abstract][Full Text] [Related]
23. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
[TBL] [Abstract][Full Text] [Related]
24. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries.
Fayorsey RN; Saito S; Carter RJ; Gusmao E; Frederix K; Koech-Keter E; Tene G; Panya M; Abrams EJ
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):e124-30. PubMed ID: 23337367
[TBL] [Abstract][Full Text] [Related]
25. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
[TBL] [Abstract][Full Text] [Related]
26. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
[TBL] [Abstract][Full Text] [Related]
27. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.
van Dijk JH; Sutcliffe CG; Munsanje B; Sinywimaanzi P; Hamangaba F; Thuma PE; Moss WJ
PLoS One; 2011 Apr; 6(4):e19006. PubMed ID: 21552521
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.
Adedimeji A; Edmonds A; Hoover D; Shi Q; Sinayobye JD; Nduwimana M; Lelo P; Nash D; Anastos K; Yotebieng M
PLoS One; 2017; 12(1):e0169871. PubMed ID: 28081230
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.
Zanoni BC; Phungula T; Zanoni HM; France H; Feeney ME
PLoS One; 2011; 6(7):e22706. PubMed ID: 21829487
[TBL] [Abstract][Full Text] [Related]
31. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
32. How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.
Slaymaker E; Todd J; Marston M; Calvert C; Michael D; Nakiyingi-Miiro J; Crampin A; Lutalo T; Herbst K; Zaba B
Glob Health Action; 2014; 7():22789. PubMed ID: 24762982
[TBL] [Abstract][Full Text] [Related]
33. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
Coffie PA; Egger M; Vinikoor MJ; Zannou M; Diero L; Patassi A; Kuniholm MH; Seydi M; Bado G; Ocama P; Andersson MI; Messou E; Minga A; Easterbrook P; Anastos K; Dabis F; Wandeler G;
BMC Infect Dis; 2017 Nov; 17(Suppl 1):706. PubMed ID: 29143625
[TBL] [Abstract][Full Text] [Related]
34. Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic-based observational cohort study in four African countries.
Esber AL; Coakley P; Ake JA; Bahemana E; Adamu Y; Kiweewa F; Maswai J; Owuoth J; Robb ML; Polyak CS; Crowell TA;
J Int AIDS Soc; 2020 Feb; 23(2):e25446. PubMed ID: 32064776
[TBL] [Abstract][Full Text] [Related]
35. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.
Taha TE; Yende-Zuma N; Brummel SS; Stranix-Chibanda L; Wambuzi Ogwang L; Dadabhai S; Chinula L; Nyati MM; Hanley S; Makanani B; Chipato T; Atuhaire P; Aizire J; Fowler MG
Lancet HIV; 2022 Jun; 9(6):e394-e403. PubMed ID: 35489365
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
[TBL] [Abstract][Full Text] [Related]
38. Persons living with HIV with advanced HIV disease: need for novel care models.
Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
[TBL] [Abstract][Full Text] [Related]
39. Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study.
Ranque B; Kitenge R; Ndiaye DD; Ba MD; Adjoumani L; Traore H; Coulibaly C; Guindo A; Boidy K; Mbuyi D; Ly ID; Offredo L; Diallo DA; Tolo A; Kafando E; Tshilolo L; Diagne I
Lancet Haematol; 2022 Mar; 9(3):e208-e216. PubMed ID: 35240076
[TBL] [Abstract][Full Text] [Related]
40. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
